Published in Biomed Res Int on August 31, 2014
Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. Expert Rev Mol Diagn (2016) 0.75
Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study. PLoS One (2016) 0.75
Hepatocytes are the Principal Source of Circulating RBP4 in Mice. Diabetes (2016) 0.75
Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res (2008) 6.47
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res (2004) 5.68
Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA (1998) 5.09
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem (2008) 2.72
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol (2008) 2.60
The structure of beta-lactoglobulin and its similarity to plasma retinol-binding protein. Nature (1987) 2.24
Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics (2005) 2.06
High-resolution serum proteomic patterns for ovarian cancer detection. Endocr Relat Cancer (2004) 1.76
Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem (2007) 1.73
Proteomic approaches to tumor marker discovery. Arch Pathol Lab Med (2002) 1.72
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin Cancer Res (2003) 1.53
Plasma proteomic pattern as biomarkers for ovarian cancer. Int J Gynecol Cancer (2006) 1.53
Protein identification methods in proteomics. Electrophoresis (2000) 1.49
Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev (1989) 1.35
Proteomics: a new approach to the study of disease. J Pathol (2000) 1.32
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer (2005) 1.26
Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br J Cancer (2004) 1.23
Proteomic analysis of human blood serum using peptide library beads. J Proteome Res (2007) 1.22
Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res (2007) 1.22
Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers. Proteomics (2004) 1.15
The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics (2009) 1.11
Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) (2009) 1.06
Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. Gynecol Oncol (1999) 1.06
High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab (2008) 1.04
Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring) (2008) 1.03
A new approach for the detection and identification of protein impurities using combinatorial solid phase ligand libraries. J Proteome Res (2006) 0.93
Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance. J Clin Endocrinol Metab (2008) 0.93
Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics. Oncol Rep (2011) 0.88
Combinatorial peptide ligand libraries for urine proteome analysis: investigation of different elution systems. Electrophoresis (2009) 0.83
Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients. Scand J Clin Lab Invest (2012) 0.81
Ovarian cancer screening: are there any options? Clin J Oncol Nurs (2005) 0.77